Skip to main content

Table 1 Baseline characteristics of enrolled patients

From: Corticosteroids in treatment of aspiration-related acute respiratory distress syndrome: results of a retrospective cohort study

Characteristics

Total (n, %)

Number

73

Age (years)

67.0 (SD 14.1)

Sex male

52 (71.2)

Admission NIHSS score

9.3 (SD 3.2)

Admission GCS score

5.6 (SD 2.0)

Smoking

30 (41.1)

Excess alcohol consumption

22 (30.1)

Pre-existing illnesses

 

 Hypertension

53 (72.6)

 Diabetes

36 (49.3)

 Coronary heart disease

14 (19.2)

 Liver disease (except for hepatic cirrhosis)

0 (0)

 Kidney disease

2 (2.7)

Chest X ray

73 (100)

Chest CT

58 (79.5)

 GGOs

40/58 (69.0)

 Consolidation opacities

31/58 (53.4)

 Pleural effusions

14/58 (24.1)

 Air bronchogram

11/58 (19.0)

Tachypnea (RR ≥ 25 breaths/min)

67 (91.8)

Fever (T ≥ 37.5 °C)

43 (58.9)

PaO2/FiO2 (mmHg)

143.5 (SD 59.0)

APACHE II score

28.2 (SD 10.4)

pH value

7.38 (SD 0.57)

Acidosis (pH < 7.35)

11 (15.1)

Albumin (g/L)

26.1 (SD 9.2)

Treatment

 

Corticosteroids

47 (64.4)

 No respiratory response

16/47 (34.0)

 Respiratory response

31/47 (66.0)

Ventilatory support

63 (86.3)

 Non-invasive ventilation alone

14/63 (22.2)

 Non-invasive ventilation followed by intubation

16/63 (25.4)

 First line invasive ventilation

33/63 (52.4)

Time from diagnosis to corticosteroids (days)

6.5 (SD 3.5)

Outcomes

 

 Duration of IMV (days)

8.5 (SD 5.5)

 Hospital LOS (days)

23.0 (SD 7.0)

 Hospital mortality

29 (39.7)

  1. Abbreviation: SD standard deviation, NIHSS National Institutes of Health Stroke Scale, GCS Glasgow Coma Scale, GGOs ground glass opacities, RR respiratory rate, APACHE Acute Physiology and Chronic Health Evaluation, PaO 2 partial pressure of oxygen in arterial blood, FiO 2 fraction of inspired oxygen, IMV invasive mechanical ventilation, LOS length-of-stay